Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Without Real Numbers to Judge, It’s More of the Same for Luckin Stock

By Chris Markoch, InvestorPlace Contributor

Investors hope Luckin stock is free of accounting fraud. But until it reports earnings, investors should assume nothing has changed.

Know Why You’re Buying (Or Not Buying) Palantir Technologies

By Chris Markoch, InvestorPlace Contributor

PLTR stock is seeing a post-election bounce which indicates that this controversial company can do business on both sides of the aisle.

Can Inovio Benefit From All Of Its Vaccine Delays?

By Chris Markoch, InvestorPlace Contributor

Shares of Inovio (NASDAQ:INO) are trading near a six-month low. The company is being battered by delays in getting its Covid-19 vaccine candidate into Phase…

The Law of Diminishing Returns Makes Sunrun Stock Look a Lot Riskier

By Chris Markoch, InvestorPlace Contributor

The affordability and demand for solar is a catalyst for Sunrun stock. But as analyst coverage increases, the growth forecast is getting weaker.

5 Vice ETFs For Safe Investment In Sin Stocks

By Chris Markoch, InvestorPlace Contributor

It's been an uneven year for sin stocks. But investors are optimistic that 2021 will be better, and these vice ETFs are great for exposure.

Load More